------------------------------
OMB APPROVAL
------------------------------
OMB Number 3235-0104
Expires: December 31, 2001
Estimated average burden
hours per response ....... 0.5
------------------------------
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 3
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
================================================================================
1. Name and Address of Reporting Person
Tricolli Mark J.
--------------------------------------------------------------------------------
(Last) (First) (Middle)
c/o Goldman, Sachs & Co.
85 Broad Street
--------------------------------------------------------------------------------
(Street)
New York New York 10004
--------------------------------------------------------------------------------
(City) (State) (Zip)
================================================================================
2. Date of Event Requiring Statement (Month/Day/Year)
6/12/00
================================================================================
3. IRS or Social Security Number of Reporting Person (Voluntary)
================================================================================
4. Issuer Name AND Ticker or Trading Symbol
ProMedCo Management Company (NASDAQ:PMCO)
================================================================================
5 Relationship of Reporting Person(s) to Issuer
(Check all applicable)
[ X ] Director [ ] 10% Owner
[ ] Officer (give title below) [ ] Other (specify below)
--------------------------------------------------------------------
================================================================================
6. If Amendment, Date of Original (Month/Day/Year)
================================================================================
7. Individual or Joint/Group Filing
[ X ] Form Filed by One Reporting Person
[ ] Form Filed by More than One Reporting Person
================================================================================
Table I -- Non-Derivative Securities Beneficially Owned
================================================================================
<TABLE>
<CAPTION>
3. Ownership Form:
2. Amount of Securities Direct (D) or
1. Title of Security Beneficially Owned Indirect (I) 4. Nature of Indirect Beneficial Ownership
(Instr. 4) (Instr. 4) (Instr. 5) (Instr.5)
------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
====================================================================================================================================
</TABLE>
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
(Print or Type Responses)
FORM 3 (continued)
Table II -- Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
================================================================================
<TABLE>
<CAPTION>
5. Owner-
3. Title and Amount of Securities ship
Underlying Derivative Security Form of
2. Date Exercisable (Instr. 4) Derivative
and Expiration Date --------------------------------- 4. Conver- Security:
(Month/Day/Year) Amount sion or Direct 6. Nature of
---------------------- or Exercise (D) or Indirect
1. Title of Derivative Date Expira- Number Price of Indirect Beneficial
Security Exer- tion of Derivative (I) Ownership
(Instr. 4) cisable Date Title Shares Security (Instr.5) (Instr. 5)
------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C>
Series A Convertible Immed. (2) Common Stock 17,000,000 (2) I (1)(4)
Preferred Stock
------------------------------------------------------------------------------------------------------------------------------------
Warrants to purchase
Series B Convertible 6/12/2003
Preferred Stock Immed. (3) Common Stock 3,125,000 (3) I (1)(4)
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
====================================================================================================================================
</TABLE>
Explanation of Responses:
See attached pages.
/s/Roger S. Begelman June 22, 2000
--------------------------------------------- -----------------------
(**)Signature of Reporting Person Date
Mark J. Tricolli by Attorney-in-Fact
** Intentional misstatements or omissions of facts constitute Federal Criminal
Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space is insufficient, see Instruction 6 for procedure.
Potential persons who are to respond to the collection of information
contained in this form are not required to respond unless the form displays
a currently valid OMB Number.
<PAGE>
FORM 3
Explanation of Responses
Item 1: Mark J. Tricolli
c/o Goldman, Sachs & Co.
85 Broad Street
New York, NY 10004
Item 2: June 12, 2000
Item 4: ProMedCo Management Company (PMCO)
------------------------------------------------------------------------------
(1) The Reporting Person is an associate of Goldman, Sachs & Co. ("Goldman
Sachs"). Goldman Sachs is an indirect wholly-owned subsidiary of The
Goldman Sachs Group, Inc. ("GS Group"). The Reporting Person disclaims
beneficial ownership of the securities reported herein except to the
extent of his pecuniary interest therein, if any.
(2) Each share of Series A Convertible Preferred Stock ("Series A
Preferred Stock") is convertible at any time at the option of the
holder into such number of fully paid and nonassessable shares of the
Company's Common Stock, par value $0.01 per share ("Common Stock"), as
is determined by dividing (x) the Series A Liquidation Preference
(defined below), as of the conversion date, by (y) the Series A
Conversion Price (defined below), as of the conversion date. The
initial conversion price for Series A Preferred Stock is $2.50 per
share, which is subject to adjustment as provided in the Certificate
of Designation of the Series A Preferred Stock (the "Series A
Conversion Price"). The "Series A Liquidation Preference" is $100.00
per share (as adjusted for any stock dividends, combinations or splits
with respect to such share), plus an amount equal to all accrued but
unpaid dividends (whether or not declared) on such share.
(3) Subject to any adjustments for capital reorganization,
reclassification and the like, each warrant may be exercised, at any
time prior to 5:00 p.m. on June 12, 2003, to purchase one share of the
Company's Series B Convertible Preferred Stock, par value $0.01 per
share (the "Series B Preferred Stock"), at an exercise price of $97.00
per share. Each share of Series B Preferred Stock is convertible at
any time at the option of the holder into such number of fully paid
and nonassessable shares of Common Stock as is determined by dividing
(x) the Series B Liquidation Preference (defined below) as of the
conversion date, by (y) the Series B Conversion Price (defined below)
as of the conversion date. The initial conversion price for Series B
Preferred Stock is $4.00 per share, which is subject to adjustment as
provided in the Certificate of Designation of the Series B Preferred
Stock (the "Series B Conversion Price"). The "Series B Liquidation
Preference" is $100.00 per share (as adjusted for any stock dividends,
combinations or splits with respect to such share), plus an amount
equal to all accrued but unpaid dividends (whether or not declared) on
such share.
(4) As of June 12, 2000, Goldman Sachs and GS Group may be deemed to own
beneficially and indirectly in the aggregate 425,000 shares of Series
A Preferred Stock and warrants to purchase 125,000 shares of Series B
Preferred Stock through certain investment partnerships of which
Goldman Sachs or affiliates of Goldman Sachs and GS Group are the
general partner or managing partner.
<PAGE>
POWER OF ATTORNEY
-----------------
The undersigned does hereby appoint Hans L. Reich and Roger S.
Begelman his true and lawful attorneys, and each of them his true and
lawful attorney, with power to act without the other, and with full power
of substitution and resubstitution, to execute for his and in his name any
Initial Statement of Beneficial Ownership of Securities on Form 3, any
Statement of Changes in Beneficial Ownership on Form 4 and any Annual
Statement of Changes in Beneficial Ownership on Form 5, or any similar or
successor form, which may be required to be filed by him with the
Securities and Exchange Commission and any and all instruments necessary or
incidental therewith, hereby granting unto said attorneys and each of them
full power and authority to do and perform in the name and on behalf of the
undersigned, and in any and all capacities, every act and thing whatsoever
required or necessary to be done in and about the premises, as fully and to
all intents and purposes as the undersigned might or could do in person,
hereby ratifying and approving the act of said attorneys and each of them.
This power of attorney shall not be affected by the subsequent
disability or incompetence of the principal. This power of attorney shall
remain in full force and effect until either revoked in writing by the
undersigned or until such time as the person or persons to whom power of
attorney has been hereby granted cease(s) to be an employee of The Goldman
Sachs Group, Inc. or one of its affiliates.
In witness thereof the undersigned hereunto signed his name this 20th
day of June 2000.
/s/Mark J. Tricolli
-------------------------
Mark J. Tricolli
